Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;27(2):79–85. [Article in Spanish] doi: 10.1016/S0212-6567(01)78778-1

Tiempos de demora en el diagnóstico del cáncer

Delays in cancer diagnosis

M Bernal Pérez a,*, FJ Gómez Bernal b, GJ Gómez Bernal c
PMCID: PMC7684002  PMID: 11256096

Abstract

Objective

A reduction in the time used to be able to diagnose an illness influences not only the well being of the patient but also the quality of the medical care. In this work, we have studied the amount of time needed to diagnose cancer.

Material and method

Descriptive methods have been used: average, median, mode and standard deviation in order to know how long it takes to diagnose and treat cancer. The data have been taken from a hospital register.

Results

The longest time elapsed between the periods appears to be the one between the first symptoms and the date the diagnosis is made, which has been calculated to be 96 days on average. The remaining time periods studied showed a time lapse of about 26 days on median.

Discussion

The median has been taken as the mesurement chosen to assess these time periods, which have been notably reduced in the last decade.

Conclusions

The performance of the primary care doctor is of great importance, as he is normally the one who is faced with the precocius symptoms, as well as with the risk factors that persist in the patients. This doctor is therefore the one who can initiate both the early diagnosis and the medical education of the patients.

Key words: Delay diagnosis, Cancer

Bibliografía

  • 1.Porta Serra M., Belloc Calmet J., Malats Riera N. Estudios españoles sobre la demora diagnóstica y terapéutica en el cáncer. Revisiones en Salud Pública. 1989;1:197–226. [Google Scholar]
  • 2.Jenicek M. Masson; Barcelona:: 1996. Epidemiología. [Google Scholar]
  • 3.Colton T. Salvat; Barcelona:: 1989. Estadística en medicina. [Google Scholar]
  • 4.Nosarti C., Crayford T., Roberts J.V., Elias E., McKenzie K., David A.S. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer. 2000;82(3):742–745. doi: 10.1054/bjoc.1999.0990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Palmeriro R., Serna A., García–Blanco P., Millan J. Factores relacionados con la demora diagnóstica en el cáncer de mama. An Med Inter. 1986;3:117–121. [Google Scholar]
  • 6.Gott C.M., Rogstad K.E., Riley V., Ahmed-Jushuf I. Delay in symptom presentation among a sample of older GUM clinic attenders. Int J STD AIDS. 1999;10:43–46. doi: 10.1258/0956462991913079. [DOI] [PubMed] [Google Scholar]
  • 7.Hook E.W., Richey C.M., Leone P., Bolan G. Delayed presentation to clinics for sexually transmitted diseases by symptomatic continuing STD morbidity. Sex Transm Dis. 1997;24:443–448. doi: 10.1097/00007435-199709000-00001. [DOI] [PubMed] [Google Scholar]
  • 8.Bianchi A., Puig X., Diloy R., Badia A., Barja J., Henríquez E. Análisis de un alta incidencia de cáncer gástrico precoz en un hospital comarcal. Estudio comparativo con el cáncer avanzado. Gastroenterol Hepatol. 1988;11:69–74. [Google Scholar]
  • 9.Flor B., García J., Fernando J., Vera F., Del Álamo A., Azofra R. Consideraciones clínico-quirúrgicas del cáncer gástrico precoz: revisión de 36 casos. Cir esp. 1987;42:42–56. [Google Scholar]
  • 10.Willcox P.A., O'Brien J.A., Abratt R.P. Lung cancer at Groote Schuur Hospital-a local perspective. S Afr Med J. 1990;78:716–720. [PubMed] [Google Scholar]
  • 11.Palacios A., Esco R., Galán C.J., Sanz J.J., Castillo A., Marín F. Sintomatología inicial y tiempo diagnostico del cáncer de pulmón. Aten Primaria. 1986;3:211–213. [Google Scholar]
  • 12.Newman L.H., Tannenbaum M., Droller M.J. Muscle-invasive bladder cancer: does it arise de novo or from pre existing superficial disease? Urology. 1988;32:58–62. doi: 10.1016/0090-4295(88)90457-8. [DOI] [PubMed] [Google Scholar]
  • 13.López Cantarero M., García J.M., Belda R., Gómez E., De la Cruz J.C. Aspectos clínicos y diagnósticos de una serie de 81 casos de cáncer de esófago. Rev Esp Enferm Apar Dig. 1986;70:211–213. [Google Scholar]
  • 14.Fisher S.g., Davis F., Nelson R., Weber L., Goldberg J., Haenszel W. A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst. 1993;85:1303–1310. doi: 10.1093/jnci/85.16.1303. [DOI] [PubMed] [Google Scholar]
  • 15.Ekström A.M., Signorello Lisa B., Hansson L.E., Bergström R., Anders R., Nyrén O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91:786–790. doi: 10.1093/jnci/91.9.786. [DOI] [PubMed] [Google Scholar]
  • 16.Harris G.J., Simson J.N. Causes of late diagnosis in cases of colorectal cancer seen in a district general hospital over a 2-year period. Ann R Coll Surg Engl. 1998;80(4):246–248. [PMC free article] [PubMed] [Google Scholar]
  • 17.Sule A.Z., Mandong B.M. Malignant colorectal tumours in patients 30 years and below: a review of 35 cases. Med Care. 2000;38(1):108–114. doi: 10.4314/cajm.v45i8.8486. [DOI] [PubMed] [Google Scholar]
  • 18.Rudy D.R., Zdon M.J. Update on colorectal cancer. Am Fam Physician. 2000;61(6):1759–1770. [PubMed] [Google Scholar]
  • 19.Ramírez A.J., Westcombe A.M., Burgess C.C., Sutton S., Littlejohns P., Richards M.A. Factors predicting delayed presentation of symptomatic breast cáncer: a systematic review. Lancet. 1999;353(9159):1127–1131. doi: 10.1016/s0140-6736(99)02142-x. [DOI] [PubMed] [Google Scholar]
  • 20.Wingo P.A., Ries L.A.G., Giovino G.A., Miller D.S., Rosenberg H.M., Shopland D.R. Annual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco Smoking. J Natl Cancer Inst. 1999;91:675–690. doi: 10.1093/jnci/91.8.675. [DOI] [PubMed] [Google Scholar]
  • 21.Pérez Cano E., Simonet Ainedo P.J., Vargas Blasco C., Castells Esteve M., Parellada Esquius N. El diagnóstico en el cáncer de prostata. Aten Primaria. 2000;25:137–141. doi: 10.1016/S0212-6567(00)78476-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Expósito Hernández J., González M.B., Aguayo de Hoyos E., Cáceres L. Demora diagnóstica en cáncer Oncología. 1998;21(9):294–305. [Google Scholar]
  • 23.Cooper G.S., Yuan Z., Stange K.C., Dennis L.K., Amini S.B., Rimm A.A. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care. 2000;38:411–421. doi: 10.1097/00005650-200004000-00008. [DOI] [PubMed] [Google Scholar]
  • 24.Baines C., Dayan R.A. Tangled web: factors likely to affect the efficacy of screening mammography. J Natl Cancer Inst. 1999;91:833–838. doi: 10.1093/jnci/91.10.833. [DOI] [PubMed] [Google Scholar]
  • 25.Bell R. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy. BMJ. 2000;320:940–941. [PubMed] [Google Scholar]
  • 26.Fowler M.C. 4 Outcomes for patients at risk for inheritable breast cancer: how the nurse practitioner can determine the proper course of action to ensure desired outcomes Nurse. Pract Forum. 1999;10:204–207. [PubMed] [Google Scholar]
  • 27.Bruner D.W., Pickett M., Joseph A., Burggraf V. Prostate cancer elder alert. Epidemiology, screening, and early detection. J Gerontol Nurs. 2000;26:6–15. doi: 10.3928/0098-9134-20000101-06. [DOI] [PubMed] [Google Scholar]
  • 28.Harris R. What is the right cancer screening rate? Ann Intern Med. 2000;132:732–734. doi: 10.7326/0003-4819-132-9-200005020-00008. [DOI] [PubMed] [Google Scholar]
  • 29.Sakorafas G.H., Tsiotou A.G. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Cancer Treat Rev. 2000;26:103–125. doi: 10.1053/ctrv.1999.0149. [DOI] [PubMed] [Google Scholar]
  • 30.Simó Cruzet E., Ureña Tapia M.M., Vernet Vernet M., Sender Palacios M.J., Larrosa Sáez P., Jovell Fernández E. Intervención del médico de familia en el diagnóstico del cáncer. Aten Primaria. 2000;26(2):104–106. doi: 10.1016/S0212-6567(00)78619-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES